Anti-allergic and anti-inflammatory effects of aqueous extract of Pogostemon cablin

Yoon,Seok Cheol; Je,In-Gyu; Cui,Xun; Park,Hae Ran; Khang,Dongwoo; Park,Jeong-Suk; Kim,Sang-Hyun; Shin,Tae-Yong

doi:10.3892/ijmm.2015.2401

Anti-allergic and anti-inflammatory effects of aqueous extract of Pogostemon cablin

Authors:
- Seok Cheol Yoon
- In-Gyu Je
- Xun Cui
- Hae Ran Park
- Dongwoo Khang
- Jeong-Suk Park
- Sang-Hyun Kim
- Tae-Yong Shin
View Affiliations

Affiliations: College of Pharmacy, Woosuk University, Jeonju 565-701, Republic of Korea, Department of Pharmacology, School of Medicine, Kyungpook National University, Daegu 700-422, Republic of Korea, Department of Molecular Medicine, Gachon University, Incheon 406-840, Republic of Korea, Department of Alternative Medicine, Nambu University, Gwangju 506-706, Republic of Korea
Published online on: November 3, 2015 https://doi.org/10.3892/ijmm.2015.2401
Pages: 217-224

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Allergic disease is caused by exposure to normally innocuous substances that activate mast cells. Mast cell-mediated allergic inflammation is closely related to a number of allergic disorders, such as anaphylaxis, allergic rhinitis, asthma and atopic dermatitis. The discovery of drugs for treating allergic disease is an interesting subject and important to human health. The aim of the present study was to investigate the anti‑allergic and anti-inflammatory effects of the aqueous extract of Pogostemon cablin (Blanco) Benth (AEPC) (a member of the Labiatae family) using mast cells, and also to determine its possible mechanisms of action. An intraperitoneal injection of compound 48/80 or a serial injection of immunoglobulin E and antigen was used to induce anaphylaxis in mice. We found that AEPC inhibited compound 48/80‑induced systemic and immunoglobulin E-mediated cutaneous anaphylaxis in a dose-dependent manner. The release of histamine from mast cells was reduced by AEPC, and this suppressive effect was associated with the regulation of calcium influx. In addition, AEPC attenuated the phorbol 12-myristate 13-acetate plus calcium ionophore A23187 (PMACI)-stimulated expression of pro-inflammatory cytokines in mast cells. The inhibitory effects of AEPC on pro-inflammatory cytokines were dependent on the activation of nuclear factor (NF)-κB and p38 mitogen-activated protein kinase (MAPK). AEPC blocked the PMACI-induced translocation of NF-κB into the nucleus by hindering the degradation of IκBα and the phosphorylation of p38 MAPK. Our results thus indicate that AEPC inhibits mast cell‑mediated allergic inflammation by suppressing mast cell degranulation and the expression of pro-inflammatory cytokines caused by reduced intracellular calcium levels and the activation of NF-κB and p38 MAPK.

View Figures

View References

1	Takizawa H: Impact of air pollution on allergic diseases. Korean J Intern Med. 26:262–273. 2011. View Article : Google Scholar : PubMed/NCBI
2	Nauta AJ, Engels F, Knippels LM, Garssen J, Nijkamp FP and Redegeld FA: Mechanisms of allergy and asthma. Eur J Pharmacol. 585:354–360. 2008. View Article : Google Scholar : PubMed/NCBI
3	Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM and Tsai M: Mast cells as 'tunable' effector and immunoregulatory cells: Recent advances. Annu Rev Immunol. 23:749–786. 2005. View Article : Google Scholar
4	Jutel M, Blaser K and Akdis CA: Histamine in allergic inflammation and immune modulation. Int Arch Allergy Immunol. 137:82–92. 2005. View Article : Google Scholar : PubMed/NCBI
5	Pandey V, Mihara S, Fensome-Green A, Bolsover S and Cockcroft S: Monomeric IgE stimulates NFAT translocation into the nucleus, a rise in cytosol Ca²⁺, degranulation, and membrane ruffling in the cultured rat basophilic leukemia-2H3 mast cell line. J Immunol. 172:4048–4058. 2004. View Article : Google Scholar : PubMed/NCBI
6	Bradding P, Feather IH, Wilson S, Bardin PG, Heusser CH, Holgate ST and Howarth PH: Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation. J Immunol. 151:3853–3865. 1993.PubMed/NCBI
7	Azzolina A, Bongiovanni A and Lampiasi N: Substance P induces TNF-alpha and IL-6 production through NF kappa B in peritoneal mast cells. Biochim Biophys Acta. 1643:75–83. 2003. View Article : Google Scholar : PubMed/NCBI
8	Kim SH, Jun CD, Suk K, Choi BJ, Lim H, Park S, Lee SH, Shin HY, Kim DK and Shin TY: Gallic acid inhibits histamine release and pro-inflammatory cytokine production in mast cells. Toxicol Sci. 91:123–131. 2006. View Article : Google Scholar
9	Shin TY, Kim SH, Suk K, Ha JH, Kim I, Lee MG, Jun CD, Kim SY, Lim JP and Eun JS: Anti-allergic effects of Lycopus lucidus on mast cell-mediated allergy model. Toxicol Appl Pharmacol. 209:255–262. 2005. View Article : Google Scholar : PubMed/NCBI
10	Hsu HC, Yang WC, Tsai WJ, Chen CC, Huang HY and Tsai YC: Alpha-bulnesene, a novel PAF receptor antagonist isolated from Pogostemon cablin. Biochem Biophys Res Commun. 345:1033–1038. 2006. View Article : Google Scholar : PubMed/NCBI
11	Zhu YP: Chinese Materia Medica. Harwood Academic Publishers; The Netherlands: pp. 307–308. 1998
12	Kocevski D, Du M, Kan J, Jing C, Lačanin I and Pavlović H: Antifungal effect of Allium tuberosum, Cinnamomum cassia, and Pogostemon cablin essential oils and their components against population of Aspergillus species. J Food Sci. 78:M731–M737. 2013. View Article : Google Scholar : PubMed/NCBI
13	Jeong JB, Choi J, Lou Z, Jiang X and Lee SH: Patchouli alcohol, an essential oil of Pogostemon cablin, exhibits anti-tumorigenic activity in human colorectal cancer cells. Int Immunopharmacol. 16:184–190. 2013. View Article : Google Scholar : PubMed/NCBI
14	Yang Y, Kinoshita K, Koyama K, Takahashi K, Tai T, Nunoura Y and Watanabe K: Anti-emetic principles of Pogostemon cablin (Blanco) Benth. Phytomedicine. 6:89–93. 1999. View Article : Google Scholar : PubMed/NCBI
15	Kiuchi F, Matsuo K, Ito M, Qui TK and Honda G: New sesquiterpene hydroperoxides with trypanocidal activity from Pogostemon cablin. Chem Pharm Bull (Tokyo). 52:1495–1496. 2004. View Article : Google Scholar
16	Ichikawa K, Kinoshita T and Sankawa U: The screening of Chinese crude drugs for Ca²⁺ antagonist activity: identification of active principles from the aerial part of Pogostemon cablin and the fruits of Prunus mume. Chem Pharm Bull (Tokyo). 37:345–348. 1989. View Article : Google Scholar
17	Guo JX, Kimura T, But PPH and Sung CK: International Collation of Traditional and Folk Medicine. World Scientific Publishing Co. Pte. Ltd; Singapore: pp. 99–100. 2001
18	Kim HH, Park SB, Lee S, Kwon TK, Shin TY, Park PH, Lee SH and Kim SH: Inhibitory effect of putranjivain A on allergic inflammation through suppression of mast cell activation. Toxicol Appl Pharmacol. 274:455–461. 2014. View Article : Google Scholar
19	Kim HH, Kim DS, Kim SW, Lim SH, Kim DK, Shin TY and Kim SH: Inhibitory effects of Diospyros kaki in a model of allergic inflammation: role of cAMP, calcium and nuclear factor-κB. Int J Mol Med. 32:945–951. 2013.PubMed/NCBI
20	Kim HH, Bae Y and Kim SH: Galangin attenuates mast cell-mediated allergic inflammation. Food Chem Toxicol. 57:209–216. 2013. View Article : Google Scholar : PubMed/NCBI
21	Itoh T, Tsukane M, Koike M, Nakamura C, Ohguchi K, Ito M, Akao Y, Koshimizu S, Nozawa Y, Wakimoto T, et al: Inhibitory effects of whisky congeners on IgE-mediated degranulation in rat basophilic leukemia RBL-2H3 cells and passive cutaneous anaphylaxis reaction in mice. J Agric Food Chem. 58:7149–7157. 2010. View Article : Google Scholar : PubMed/NCBI
22	Bae Y, Lee S and Kim SH: Chrysin suppresses mast cell-mediated allergic inflammation: involvement of calcium, caspase-1 and nuclear factor-κB. Toxicol Appl Pharmacol. 254:56–64. 2011. View Article : Google Scholar : PubMed/NCBI
23	Choi JK, Oh HM, Lee S, Park JW, Khang D, Lee SW, Lee WS, Rho MC and Kim SH: Oleanolic acid acetate inhibits atopic dermatitis and allergic contact dermatitis in a murine model. Toxicol Appl Pharmacol. 269:72–80. 2013. View Article : Google Scholar : PubMed/NCBI
24	Galli SJ and Tsai M: IgE and mast cells in allergic disease. Nat Med. 18:693–704. 2012. View Article : Google Scholar : PubMed/NCBI
25	Kalesnikoff J and Galli SJ: New developments in mast cell biology. Nat Immunol. 9:1215–1223. 2008. View Article : Google Scholar : PubMed/NCBI
26	Ma HT and Beaven MA: Regulators of Ca²⁺ signaling in mast cells: potential targets for treatment of mast cell-related diseases? Adv Exp Med Biol. 716:62–90. 2011. View Article : Google Scholar
27	Galli SJ, Tsai M and Piliponsky AM: The development of allergic inflammation. Nature. 454:445–454. 2008. View Article : Google Scholar : PubMed/NCBI
28	Arbabi S and Maier RV: Mitogen-activated protein kinases. Crit Care Med. 30(Suppl 1): S74–S79. 2002. View Article : Google Scholar : PubMed/NCBI
29	Beyaert R, Cuenda A, Vanden Berghe W, Plaisance S, Lee JC, Haegeman G, Cohen P and Fiers W: The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor. EMBO J. 15:1914–1923. 1996.PubMed/NCBI
30	Boden SR and Wesley Burks A: Anaphylaxis: a history with emphasis on food allergy. Immunol Rev. 242:247–257. 2011. View Article : Google Scholar : PubMed/NCBI
31	Jutel M, Watanabe T, Akdis M, Blaser K and Akdis CA: Immune regulation by histamine. Curr Opin Immunol. 14:735–740. 2002. View Article : Google Scholar : PubMed/NCBI
32	Möller A, Henz BM, Grützkau A, Lippert U, Aragane Y, Schwarz T and Krüger-Krasagakes S: Comparative cytokine gene expression: regulation and release by human mast cells. Immunology. 93:289–295. 1998. View Article : Google Scholar : PubMed/NCBI
33	Sillaber C, Bevec D, Butterfield JH, Heppner C, Valenta R, Scheiner O, Kraft D, Lechner K, Bettelheim P and Valent P: Tumor necrosis factor alpha and interleukin-1 beta mRNA expression in HMC-1 cells: differential regulation of gene product expression by recombinant interleukin-4. Exp Hematol. 21:1271–1275. 1993.PubMed/NCBI
34	Hu ZQ, Kobayashi K, Zenda N and Shimamura T: Tumor necrosis factor-alpha- and interleukin-6-triggered mast cell development from mouse spleen cells. Blood. 89:526–533. 1997.PubMed/NCBI
35	Walsh LJ, Trinchieri G, Waldorf HA, Whitaker D and Murphy GF: Human dermal mast cells contain and release tumor necrosis factor alpha, which induces endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci USA. 88:4220–4224. 1991. View Article : Google Scholar : PubMed/NCBI
36	Mican JA, Arora N, Burd PR and Metcalfe DD: Passive cutaneous anaphylaxis in mouse skin is associated with local accumulation of interleukin-6 mRNA and immunoreactive interleukin-6 protein. J Allergy Clin Immunol. 90:815–824. 1992. View Article : Google Scholar : PubMed/NCBI
37	Dienz O and Rincon M: The effects of IL-6 on CD4 T cell responses. Clin Immunol. 130:27–33. 2009. View Article : Google Scholar :
38	Silvestri M, Bontempelli M, Giacomelli M, Malerba M, Rossi GA, Di Stefano A, Rossi A and Ricciardolo FL: High serum levels of tumour necrosis factor-alpha and interleukin-8 in severe asthma: Markers of systemic inflammation? Clin Exp Allergy. 36:1373–1381. 2006. View Article : Google Scholar : PubMed/NCBI
39	Karin M: NF-kappaB as a critical link between inflammation and cancer. Cold Spring Harb Perspect Biol. 1:a0001412009. View Article : Google Scholar
40	Manthey CL, Wang SW, Kinney SD and Yao Z: SB202190, a selective inhibitor of p38 mitogen-activated protein kinase, is a powerful regulator of LPS-induced mRNAs in monocytes. J Leukoc Biol. 64:409–417. 1998.PubMed/NCBI
41	Shapiro L and Dinarello CA: Osmotic regulation of cytokine synthesis in vitro. Proc Natl Acad Sci USA. 92:12230–12234. 1995. View Article : Google Scholar : PubMed/NCBI